The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000546.6(TP53):c.559+5G>A

CA645588866

490175 (ClinVar)

Gene: TP53 (HGNC:7157)
Condition: Li-Fraumeni syndrome (MONDO:0018875)
Inheritance Mode: Autosomal dominant inheritance
UUID: bdd477f7-d608-49a9-b461-7036f0a2efe6
Approved on: 2026-01-06
Published on: 2026-01-14

HGVS expressions

NM_000546.6:c.559+5G>A
NM_000546.6(TP53):c.559+5G>A
NC_000017.11:g.7675048C>T
CM000679.2:g.7675048C>T
NC_000017.10:g.7578366C>T
CM000679.1:g.7578366C>T
NC_000017.9:g.7519091C>T
NG_017013.2:g.17503G>A
ENST00000503591.2:c.559+5G>A
ENST00000508793.6:c.559+5G>A
ENST00000509690.6:c.163+5G>A
ENST00000514944.6:c.280+5G>A
ENST00000604348.6:c.538+5G>A
ENST00000269305.9:c.559+5G>A
ENST00000269305.8:c.559+5G>A
ENST00000359597.8:c.559+5G>A
ENST00000413465.6:c.559+5G>A
ENST00000420246.6:c.559+5G>A
ENST00000445888.6:c.559+5G>A
ENST00000455263.6:c.559+5G>A
ENST00000504290.5:c.163+5G>A
ENST00000504937.5:c.163+5G>A
ENST00000505014.5:n.815+5G>A
ENST00000509690.5:c.163+5G>A
ENST00000510385.5:c.163+5G>A
ENST00000514944.5:c.280+5G>A
ENST00000574684.1:n.67+5G>A
ENST00000610292.4:c.442+5G>A
ENST00000610538.4:c.442+5G>A
ENST00000610623.4:c.82+5G>A
ENST00000615910.4:c.526+5G>A
ENST00000617185.4:c.559+5G>A
ENST00000618944.4:c.82+5G>A
ENST00000619186.4:c.82+5G>A
ENST00000619485.4:c.442+5G>A
ENST00000620739.4:c.442+5G>A
ENST00000622645.4:c.442+5G>A
ENST00000635293.1:c.442+5G>A
NM_000546.5:c.559+5G>A
NM_001126112.2:c.559+5G>A
NM_001126113.2:c.559+5G>A
NM_001126114.2:c.559+5G>A
NM_001126115.1:c.163+5G>A
NM_001126116.1:c.163+5G>A
NM_001126117.1:c.163+5G>A
NM_001126118.1:c.442+5G>A
NM_001276695.1:c.442+5G>A
NM_001276696.1:c.442+5G>A
NM_001276697.1:c.82+5G>A
NM_001276698.1:c.82+5G>A
NM_001276699.1:c.82+5G>A
NM_001276760.1:c.442+5G>A
NM_001276761.1:c.442+5G>A
NM_001276695.2:c.442+5G>A
NM_001276696.2:c.442+5G>A
NM_001276697.2:c.82+5G>A
NM_001276698.2:c.82+5G>A
NM_001276699.2:c.82+5G>A
NM_001276760.2:c.442+5G>A
NM_001276761.2:c.442+5G>A
NM_001126112.3:c.559+5G>A
NM_001126113.3:c.559+5G>A
NM_001126114.3:c.559+5G>A
NM_001126115.2:c.163+5G>A
NM_001126116.2:c.163+5G>A
NM_001126117.2:c.163+5G>A
NM_001126118.2:c.442+5G>A
NM_001276695.3:c.442+5G>A
NM_001276696.3:c.442+5G>A
NM_001276697.3:c.82+5G>A
NM_001276698.3:c.82+5G>A
NM_001276699.3:c.82+5G>A
NM_001276760.3:c.442+5G>A
NM_001276761.3:c.442+5G>A
More

Uncertain Significance

Met criteria codes 3
PM2_Supporting PP4 PVS1_Moderate
Not Met criteria codes 13
BP4 BP7 BA1 PS2 PS3 PS4 PP1 PP3 PM1 BS2 BS4 BS3 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen TP53 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for TP53 Version 2.4.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
TP53 VCEP
The NM_000546.6:c.559+5G>A variant in TP53 is an intronic variant which is located in intron 5/10. Splicing assay data provides some experimental evidence that this variant may result in RNA transcript(s) with loss of function, however leakiness and intron retention cannot be ruled out (PVS1_Moderate (RNA); Internal lab contributor). This variant received a total of 0.5 points across 1 proband (PS4 not met; PMIDs, ClinVar SCVs, Internal lab contributors). At least one individual with this variant was found to have a variant allele fraction of 5-35%, which is a significant predictor of variant pathogenicity (PP4, PMID: 34906512, Internal lab contributors). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria to be classified as variant of uncertain clinical significance for Li Fraumeni syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen TP53 VCEP: PVS1_Moderate, PP4, PM2_Supporting. (Bayesian Points: 4; VCEP specifications version 2.4)
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v4.1.0 (PM2_Supporting).
PP4
At least one individual with this variant was found to have a variant allele fraction of 5-35%, which is a significant predictor of variant pathogenicity (PP4, PMID: 34906512, Internal lab contributors).
PVS1_Moderate
Splicing assay data provides experimental evidence that this variant results in RNA transcript(s) with loss of function (PVS1_Moderate (RNA); Internal lab contributor). Internal lab provider has performed RNA studies but observed leakiness with intro retention. Due to lack of definitive internal data PVS1 conservatively downgraded two strengths from Very Stong to Moderate.
Not Met criteria codes
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
This variant received a total of 0.5 points across 1 proband (PS4 not met; PMIDs, ClinVar SCVs, Internal lab contributors).
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
Met but cannot be applied in combination with PVS1 The computational splicing predictor SpliceAI gives a score of 0.22 acceptor loss, 0.21 donor loss, and 0.56 donor gain, predicting that the variant has an impact on splicing (score threshold > 0.20) (PP3).
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.